Delivery Order SPE2DR25D2212-SPE2DR26FB9LV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,482.11 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on December 11, 2025, with completion expected by December 12, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $15,273.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Jardiance 10 mg tablets (90-count) valued at $11,906.66. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The order is due for completion by November 13, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a $11,651.61 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price delivery order, which is not subject to any set-aside designation, represents a competitively awarded contract under the company's existing indefinite delivery vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order valued at $18,079.54 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $13,245.31. This firm fixed-price delivery order, with an ultimate completion date of December 2, 2025, represents a competitively awarded, non-set-aside contract. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $4,892.01 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,047.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs through AmerisourceBergen's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9LVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,049.62 to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a critical vendor for federal medical procurement, AmerisourceBergen Drug Corp leverages this contract vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with Jardiance being one of many therapeutic medications included within its extensive portfolio of approved pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.0k | 12/15/25 |